IP Decisions
Subject | IP High Court Decision, 2022Heo1827IP High Court Decision, 2022Heo1827 (Case Concerning Composition for Inhibiting Angiogenesis Using Extracts of Zizania latifolia) | ||||
---|---|---|---|---|---|
Writer | International IP Law Research Center | Date | 2025.03.13 | Hit | 368 |
Attachments | [4] 2022Heo1827.pdf | ||||
IP High Court Decision, 2022Heo1827 (Case Concerning Composition for Inhibiting Angiogenesis Using Extracts of Zizania latifolia) Claim 1 can be easily derived by a skilled person based on the prior art and thus is denied of an inventive step. Meanwhile, in a patent application consisting of two or more claims, if even one claim has grounds for rejection, the entire application must be rejected. Since the inventive step of Claim 1 is denied and it cannot be granted a patent, the subject application cannot be granted a patent and there is no need to further examine the remaining claims. Thus, the IPTAB Decision in line with this conclusion is lawful. |
Previous | IP High Court Decision, 2022Heo3809 (Case Con... |
---|---|
Next | IP High Court Decision, 2022Heo1216 (Case Con... |